israeli
Teva says Allergan deal to close ‘any time’, expects U.S. antitrust clearance
July 13, 2016 by creative · Leave a Comment
NEW YORK/TEL AVIV (Reuters) – Teva Pharmaceutical Industries Ltd said on Wednesday it expected its $40 billion deal to buy Allergan Plc's generics business to close “at any time,” even as the companies extended the deadline for completing the transaction to October to allow more time for the U.S. antitrust review. “We …
See the original post here:
Teva says Allergan deal to close ‘any time’, expects U.S. antitrust clearance